Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Huiyuan Capital, also known as Acusea, is a venture capital firm founded in 2017 and based in China, with a significant presence in Palo Alto, California. The firm operates under the parent company Zhuhai Huajin Capital Co., Ltd. and is structured as a cross-border investment organization. Huiyuan Capital primarily focuses on growth equity investments, targeting technology and real estate sectors. The firm aims to support the development of industrial entities and help growth-stage tech companies become leaders in their respective categories.
Huiyuan Capital manages dual fund vehicles in both USD and RMB, allowing it to invest in a diverse range of sectors including big data, enterprise, consumer, education, internet & mobile, smart manufacturing, and infrastructure technology. The firm’s investment strategy emphasizes scaling businesses rather than early-stage investments, positioning itself as a partner for companies looking to expand in both the US and Chinese markets.
Huiyuan Capital invests in a variety of sectors, including consumer, smart manufacturing, big data, enterprise, education, internet & mobile, and infrastructure technology. The firm specifically targets growth-stage companies, focusing on those that are poised for significant scaling opportunities. This investment strategy is designed to help companies transition into 'next-generation category leaders' within their respective industries.
The firm operates with a cross-border investment thesis, facilitating deals between the US and China. This dual focus allows Huiyuan Capital to leverage its expertise in both markets, providing strategic support to portfolio companies as they navigate growth challenges. The firm seeks to partner with founders who demonstrate strong leadership potential and a clear vision for their companies, emphasizing the importance of operational excellence and market adaptability.
As of now, specific portfolio companies of Huiyuan Capital have not been publicly disclosed. The firm has not surfaced any notable exits or current investments in its public profiles. However, it is known that Huiyuan Capital invests in sectors such as consumer technology and smart manufacturing, which may include companies in these areas.
Given the firm's focus on growth-stage investments, it is likely that their portfolio consists of companies that are scaling operations and seeking to expand their market presence, particularly in the US and Chinese markets. The lack of publicly available information on specific investments may indicate a low-profile investment strategy or challenges in deal activity due to the current geopolitical climate affecting cross-border investments.
Jiang Hermosa serves as the Deputy Investment Director at Huiyuan Capital. She has a background in investment management and has been involved in various growth-stage investments since joining the firm.
Zonghui Zhang holds the position of Vice President. His expertise lies in identifying and evaluating investment opportunities, particularly in the technology sector.
Georgiana Zhou is an Analyst at Huiyuan Capital, contributing to market research and analysis to support investment decisions.
Xiaodong Bai works as a Manager of Investment at the parent company, Huajin Capital, where he focuses on cross-border investment strategies.
To pitch Huiyuan Capital, founders should visit their website at huajinct.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications. While specific response time expectations are not provided, founders should anticipate a thorough review process given the firm's focus on growth-stage investments.
As of now, there have been no recent public announcements or notable activities reported for Huiyuan Capital since its founding in 2017. The firm has maintained a low profile, and no specific investments or exits have been documented in public sources.
Given the current geopolitical climate and the challenges associated with cross-border investments, Huiyuan Capital's activity may have been limited. Founders interested in this firm should monitor for any updates or changes in their investment strategy moving forward.
What are Huiyuan Capital's investment criteria?
Huiyuan Capital focuses on growth-stage companies across various sectors, particularly in technology and real estate. The firm looks for businesses that demonstrate strong leadership, a clear market vision, and the potential to become category leaders.
How can I pitch to Huiyuan Capital?
Founders can pitch Huiyuan Capital through their website at huajinct.com. It is advisable to include a detailed business plan, market analysis, and information about the founding team in the pitch deck.
What makes Huiyuan Capital different from other VCs?
Huiyuan Capital operates with a unique cross-border investment thesis, focusing on bridging opportunities between the US and Chinese markets. This allows them to provide strategic support tailored to companies looking to expand internationally.
What is the typical check size for investments?
While specific check sizes are not disclosed, Huiyuan Capital primarily invests in growth-stage companies, which typically require larger funding rounds compared to early-stage investments.
What is the geographic focus of Huiyuan Capital?
The firm invests globally, with a strong emphasis on North America and Asia, particularly in the US and China. This geographic focus aligns with their cross-border investment strategy.
What kind of support does Huiyuan Capital provide post-investment?
Huiyuan Capital offers strategic support to its portfolio companies, leveraging its expertise in both the US and Chinese markets to facilitate growth and expansion.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.